A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: XZP-3287+Fulvestrant|DRUG: Placebo + Fulvestrant
Sponsor: Xuanzhu Biopharmaceutical Co., Ltd.